In this handout photo released by Russian Direct Investment Fund, a view shows a phial of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia. Sputnik-Light is based on the same special structures (carrier vectors) as in two-dose Russian Gam-COVID-VAK (trademark "Sputnik V") vaccine. Russia has described Sputnik-Light, which could be used for export, as a possible temporary solution to help countries with high infection rates make their vaccine supplies go further. Editorial use only, no archive, no commercial use.
- Package: Russia Coronavirus Vaccine
- Categories: Social Issues, Health, Science & Technology
- Location: Moscow, Russia
- Event date: 02.03.2021
- Date published: 02.03.2021
- Credit: Sputnik
- Source: Russian Direct Investment Fund (RDIF)
- Original: Digital
- Media: JPEG, 613x430px, 147Kb
- Job-ID: fd6a4102fabf474b